Overview
- Minot Light reported a net return of 7.6% for Q3 2025 versus a 17.1% gain for its micro-cap benchmark.
- Arq was profiled as a vertically integrated U.S. activated carbon producer with Five Forks Mine and Corbin, Kentucky feedstock, where CEO Robert Rasmus expanded gross margins from 28% to over 39% in the last year and delivered positive FY24 operating cash flow.
- Lucid Diagnostics, cited as a key detractor, markets FDA‑approved EsoGuard, with adoption constrained by reimbursement, and a September Medicare Contractor Advisory Committee call conveyed very positive sentiment toward the test’s clinical utility; Q3 revenue was $1.2 million.
- Stran & Company was presented as an overlooked, profitable micro-cap whose revenue has grown from $30 million in FY19 to over $100 million, benefiting from scale-driven direct manufacturer relationships and an acquisition strategy to expand into new verticals.
- Insider Monkey data show hedge fund ownership rising to 14 for Arq and 11 for Lucid, with Stran steady at 4, reflecting gradually increasing but selective institutional interest in these names.